Date published: 2026-3-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

VAC14 Inhibitors

VAC14 inhibitors belong to a class of chemical compounds that have been identified as potential modulators of the vacuole membrane protein 1 homolog (VAC14). VAC14 is a crucial regulatory protein involved in the phosphoinositide signaling pathway, which plays a vital role in diverse cellular processes, including membrane trafficking, endocytosis, and cell survival. These inhibitors are designed to selectively target VAC14 and interfere with its activity, aiming to elucidate its role in cellular signaling. The chemical structures of VAC14 inhibitors can vary widely, ranging from small molecules to peptides. Researchers use various approaches, including high-throughput screening and structure-based design, to discover and develop these inhibitors. These efforts are critical in understanding the molecular interactions between the inhibitors and VAC14, helping to guide the rational design of more potent and selective compounds.

The discovery and study of VAC14 inhibitors have provided valuable insights into the complex phosphoinositide signaling network and its impact on cellular processes. By selectively targeting VAC14, researchers can investigate its precise role in controlling phosphoinositide levels and affecting downstream signaling events. Additionally, these inhibitors offer valuable tools for dissecting the regulatory mechanisms that govern cellular trafficking and organelle function. The characterization of VAC14 inhibitors and their effects on cellular pathways contribute to our understanding of the fundamental biology of cells and the intricate regulatory networks that underlie their behavior. These compounds are instrumental in exploring the molecular basis of diseases linked to phosphoinositide dysregulation and VAC14-related disorders.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a well-known inhibitor of phosphoinositide 3-kinases (PI3Ks) and has also been reported to inhibit vacIt blocks the activity of vac14 in the phosphatidylinositol signaling pathway, which plays a crucial role in various cellular processes, including cell growth, survival, and vesicular trafficking.

SAR405

1523406-39-4sc-507416
1 mg
$125.00
(0)

SAR405 is a potent and selective inhibitor of class III PI3K/VPS34, and it has been shown to inhibit vac14 as part of the PI3K/VPS34 complex. This inhibition affects autophagy and endosome-lysosome trafficking pathways, making it a valuable tool for studying these cellular processes.

Apilimod

541550-19-0sc-480051
sc-480051A
100 mg
1 g
$428.00
$2652.00
5
(0)

Apilimod is a compound that inhibits vac14 and has been investigated in research studies for autoimmune and inflammatory diseases. It exerts its effects by targeting vac14 and disrupting autophagy and cytokine production in immune cells.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

ABT-199 is primarily known as a B-cell lymphoma 2 (BCL-2) inhibitor, but it has been reported to inhibit vac14 as well.

PI-103

371935-74-9sc-203193
sc-203193A
1 mg
5 mg
$33.00
$131.00
3
(1)

PI103 is a dual inhibitor of PI3K and mammalian target of rapamycin (mTOR) and can also impact vac14 activity. It has been employed to study the crosstalk between PI3K/mTOR and vac14 signaling in cancer cells.

PKI 402

1173204-81-3sc-476659
5 mg
$480.00
(0)

PKI-402 is a multi-kinase inhibitor that targets PI3Ks, mTOR, and other kinases. By inhibiting PI3K, PKI-402 indirectly affects vac14 activity, influencing cellular signaling pathways and responses.